These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23312225)

  • 1. Biomarkers of ovarian response: current and future applications.
    Nelson SM
    Fertil Steril; 2013 Mar; 99(4):963-9. PubMed ID: 23312225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
    La Marca A; Sunkara SK
    Hum Reprod Update; 2014; 20(1):124-40. PubMed ID: 24077980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian response biomarkers: physiology and performance.
    Iliodromiti S; Nelson SM
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):182-6. PubMed ID: 25919234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibilities and limits of ovarian reserve testing in ART.
    La Marca A; Argento C; Sighinolfi G; Grisendi V; Carbone M; D'Ippolito G; Artenisio AC; Stabile G; Volpe A
    Curr Pharm Biotechnol; 2012 Mar; 13(3):398-408. PubMed ID: 21657996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.
    La Marca A; Sighinolfi G; Argento C; Grisendi V; Casarini L; Volpe A; Simoni M
    Fertil Steril; 2013 Mar; 99(4):970-8.e1. PubMed ID: 23380184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
    La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
    Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers.
    Grisendi V; La Marca A
    Minerva Ginecol; 2017 Jun; 69(3):250-258. PubMed ID: 28271699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen.
    Freour T; Masson D; Dessolle L; Allaoua D; Dejoie T; Mirallie S; Jean M; Barriere P
    Arch Gynecol Obstet; 2012 Apr; 285(4):1177-82. PubMed ID: 22183426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M; Skull JD; Ledger WL
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.
    La Marca A; Papaleo E; Grisendi V; Argento C; Giulini S; Volpe A
    BJOG; 2012 Sep; 119(10):1171-9. PubMed ID: 22805536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antral follicle count: practical recommendations for better standardization.
    Broekmans FJ; de Ziegler D; Howles CM; Gougeon A; Trew G; Olivennes F
    Fertil Steril; 2010 Aug; 94(3):1044-51. PubMed ID: 19589513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
    Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
    Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.
    Lekamge DN; Lane M; Gilchrist RB; Tremellen KP
    J Assist Reprod Genet; 2008; 25(11-12):515-21. PubMed ID: 18972201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer].
    Chen SL; Xia R; Chen X; Luo YQ; Wang LL; Wu YQ; Shi XY; Zheng HY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):572-7. PubMed ID: 21515446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian aging: latest thoughts on assessment and management.
    Younis JS
    Curr Opin Obstet Gynecol; 2011 Dec; 23(6):427-34. PubMed ID: 21897233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.